Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
152.6 DKK | +1.60% | -1.10% | +50.79% |
May. 30 | Alk's European Registration Application for Itulazax for Pneumiatric Indication Accepted for Review | CI |
May. 03 | Transcript : ALK-Abelló A/S, Q1 2024 Earnings Call, May 03, 2024 |
Sales 2024 * | 5.39B 784M | Sales 2025 * | 6B 873M | Capitalization | 33.75B 4.91B |
---|---|---|---|---|---|
Net income 2024 * | 771M 112M | Net income 2025 * | 1.13B 164M | EV / Sales 2024 * | 6.21 x |
Net cash position 2024 * | 248M 36.1M | Net cash position 2025 * | 1.07B 156M | EV / Sales 2025 * | 5.44 x |
P/E ratio 2024 * |
42.6
x | P/E ratio 2025 * |
29.9
x | Employees | 2,828 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.05% |
Latest transcript on ALK-Abelló A/S
1 day | +1.60% | ||
1 week | -1.10% | ||
1 month | +16.93% | ||
3 months | +18.75% | ||
6 months | +60.97% | ||
Current year | +50.79% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Halling
CEO | Chief Executive Officer | 47 | Dec. 31 |
Director of Finance/CFO | 52 | 23-05-31 | |
Chief Tech/Sci/R&D Officer | - | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 21-03-17 | |
Anders Hedegaard
CHM | Chairman | 63 | 20-03-10 |
Director/Board Member | 64 | 15-03-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.03% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 152.6 | +1.60% | 427,750 |
24-05-30 | 150.2 | -0.79% | 290,387 |
24-05-29 | 151.4 | -1.11% | 139,962 |
24-05-28 | 153.1 | +0.07% | 143,011 |
24-05-27 | 153 | -0.84% | 130,939 |
Delayed Quote Nasdaq Copenhagen, May 31, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.79% | 4.91B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- ALK B Stock